Search results
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 5 days agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 5 days agoAlthough the revenue and EPS for Biogen (BIIB) give a sense of how its business performed in the...
Biogen cost cuts drive profit rise, as Alzheimer's drug off to slow start
Arizona Daily Sun· 5 days agoBiogen reported a quarterly profit that topped Wall Street estimates, helped by cost cutting, as the...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 3 days agoHowever, revenues of $2.29 billion were down 7% year over year on both reported and...
William Blair Weighs in on Biogen Inc.’s Q3 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 9 hours agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair upped their Q3 2024 earnings per share (EPS) estimates for shares of Biogen in a report issued on Thursday, April ...
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Reuters via Yahoo Finance· 5 days agoBiogen beat Wall Street estimates for first-quarter profit on Wednesday, helped by a series of cost-cutting measures as older drugs face fierce competition. The company also said its Alzheimer's ...
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoThe company's flagship products, such as TECFIDERA and AVONEX, continue to dominate the multiple sclerosis market. Moreover, the recent acquisition of...
Biogen cost cuts drive profit beat, Alzheimer's drug sales jump By Reuters
Investing.com· 5 days agoThe launch has led to profound changes in how doctors treat Alzheimer's patients, and challenges...
Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves
Market Watch· 5 days agogained 5.5% premarket on Wednesday after the company reported first-quarter profit that beat...
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
Investor's Business Daily· 5 days agoAdjusted earnings, on the other hand, rose 8% to $3.67 a share and topped estimates for $3.45....